Medtronic received information that a journal article entitled ¿long-term results after correction of persistent truncus arteriosus in 83 patients¿, doi:10.1016/j.Ejcts.2009.12.022, analyzed long-term results after correction/repair of truncus arteriosus in one institution over a 28 year span.Of the 83 patients, repair with reconstruction of the right ventricular to pulmonary artery continuity was performed with a valved conduit in 80 patients, and other methods in the remaining three patients.Within the study time frame 27 deaths occurred, 19 of which were ¿early¿ (mean 4.1 days post-operative) with causes of heart failure (n=11), multiple organ failure (n=3), sepsis (n=2), pulmonary hypertensive crisis (n=2), and sudden death (n=1).The remaining eight deaths occurred ¿late¿ (median 68 days post-operative) with causes of heart failure (n=3), sepsis (n=2), respiratory failure (n=2), and other (n=1).Other non-death adverse events included: 41 re-operations for conduit dysfunction (with a mean of 5.8 years post-operative), 12 trunca l valve replacements, 11 balloon dilatation or stents for conduit obstruction, pulmonary branch stenosis, aortic arch obstruction, orvena cava stenosis.Thirteen medtronic products were implanted in the study population, including hancock bioprosthetic valved conduit (n=12) and contegra pulmonary valved conduit (n=1).None of the observations stated in the article were clearly associated with medtronic products.
|